Modulation of Monoamine Transporters by Common Biogenic Amines via Trace Amine-Associated Receptor 1 and Monoamine Autoreceptors in Human Embryonic Kidney 293 Cells and Brain Synaptosomes

@article{Xie2008ModulationOM,
  title={Modulation of Monoamine Transporters by Common Biogenic Amines via Trace Amine-Associated Receptor 1 and Monoamine Autoreceptors in Human Embryonic Kidney 293 Cells and Brain Synaptosomes},
  author={Zhihua Xie and Susan Westmoreland and Gregory M. Miller},
  journal={Journal of Pharmacology and Experimental Therapeutics},
  year={2008},
  volume={325},
  pages={629 - 640}
}
In brain monoaminergic systems, common biogenic amines, including dopamine, norepinephrine, and serotonin, serve as neurotransmitters. Monoamine autoreceptors provide feedback regulation in neurotransmitter release, and monoamine transporters clear the released neurotransmitters to control synaptic signaling. Recently, trace amine-associated receptor 1 (TAAR1) has been found to be expressed in brain monoaminergic nuclei and activated by common biogenic amines in vitro. This study used… 

Figures from this paper

β-Phenylethylamine Alters Monoamine Transporter Function via Trace Amine-Associated Receptor 1: Implication for Modulatory Roles of Trace Amines in Brain
  • Z. Xie, G. Miller
  • Biology, Chemistry
    Journal of Pharmacology and Experimental Therapeutics
  • 2008
TLDR
Results reveal that β-PEA alters monoamine transporter function via interacting with TAAR1 but not monoamine autoreceptors, which may reveal a common mechanism by which trace amines exert modulatory effects on monoamine transporters in brain.
Trace amine-associated receptor 1 as a monoaminergic modulator in brain.
Brain-Specific Overexpression of Trace Amine-Associated Receptor 1 Alters Monoaminergic Neurotransmission and Decreases Sensitivity to Amphetamine
TLDR
Overall, these data show that Taar1 brain overexpression causes hyposensitivity to amphetamine and alterations of monoaminergic neurotransmission and suggest that in vivo the receptor is either constitutively active and/or tonically activated by ambient levels of endogenous agonist(s).
Trace Amines and the Trace Amine-Associated Receptor 1: Pharmacology, Neurochemistry, and Clinical Implications
TLDR
TAAR1 is uniquely positioned to exert direct control over DA and 5-HT neuronal firing and release, which has profound implications for understanding the pathophysiology of, and therefore designing more efficacious therapeutic interventions for, a range of neuropsychiatric disorders that involve aminergic dysregulation.
The Role of Biogenic Amine Transporters in Trace Amine–Associated Receptor 1 Regulation of Methamphetamine-Induced Neurotoxicity
TLDR
It is demonstrated that a functional TAAR1 protects a specific subcellular fraction of VMAT2, but not the dopamine transporter, from methamphetamine-induced effects, suggesting new directions in pharmacotherapeutic development for neurodegenerative disorders.
A Receptor Mechanism for Methamphetamine Action in Dopamine Transporter Regulation in Brain
  • Z. Xie, G. Miller
  • Biology, Chemistry
    Journal of Pharmacology and Experimental Therapeutics
  • 2009
TLDR
Findings demonstrate a mediatory role of TAAR1 in methamphetamine action in DAT regulation and implicate this receptor as a potential target of therapeutics drugs for methamphetamine addiction.
Differential Modulation of Beta-Adrenergic Receptor Signaling by Trace Amine-Associated Receptor 1 Agonists
TLDR
Molecular details of TAAR1-ligand promiscuity are pointed to and specific trace amines are identified as allosteric or orthosteric ligands of particular β-adrenergic receptor subtypes are identified.
The Trace Amine-Associated Receptor 1 Agonist 3-Iodothyronamine Induces Biased Signaling at the Serotonin 1b Receptor
TLDR
Evidence is found for 5-HT1b as a new receptor target for 3-T1AM, albeit with a different signaling effect than the endogenous ligand, and a complex interrelation of signaling effects between the investigated GPCRs and respective ligands.
The Case for TAAR1 as a Modulator of Central Nervous System Function
TLDR
The bulk of evidence points to a significant physiological role of TAAR1 in the modulation of central nervous system function and a potential pharmacological role ofTAAR1 agonists in neurology and/or psychiatry, but many crucial issues require further investigation.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 48 REFERENCES
β-Phenylethylamine Alters Monoamine Transporter Function via Trace Amine-Associated Receptor 1: Implication for Modulatory Roles of Trace Amines in Brain
  • Z. Xie, G. Miller
  • Biology, Chemistry
    Journal of Pharmacology and Experimental Therapeutics
  • 2008
TLDR
Results reveal that β-PEA alters monoamine transporter function via interacting with TAAR1 but not monoamine autoreceptors, which may reveal a common mechanism by which trace amines exert modulatory effects on monoamine transporters in brain.
Rhesus Monkey Trace Amine-Associated Receptor 1 Signaling: Enhancement by Monoamine Transporters and Attenuation by the D2 Autoreceptor in Vitro
TLDR
Data reveal a broad agonist spectrum for TAar1, a functional relation of TAAR1 with monoamine transporters and D2s, and a mechanism by which D2 receptor drugs can influence brain monoaminergic function and have efficacy through affectingTAAR1 signaling.
Trace Amine-Associated Receptor 1 Is a Modulator of the Dopamine Transporter
  • Z. Xie, G. Miller
  • Biology, Chemistry
    Journal of Pharmacology and Experimental Therapeutics
  • 2007
TLDR
Evidence that TAAR1 is involved in functional regulation of DAT is provided and suggests that TAar1 is a potentially important target for therapeutics for methamphetamine addiction.
Primate Trace Amine Receptor 1 Modulation by the Dopamine Transporter
TLDR
The cloning of a highly homologous TA1 from rhesus monkey and demonstration that rhTA1 receptors are activated by drugs of abuse, indicate that nonhuman primates may serve to model physiological and pharmacological TA1-mediated responses in humans.
Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor.
TLDR
The discovery and pharmacological characterization of a rat G protein-coupled receptor that stimulates the production of cAMP when exposed to the trace amines p-tyramine, beta-phenethylamine, tryptamine, and octopamine and the discovery that amphetamines are potent rTAR1 agonists suggests that the effects of these widely used drugs may be mediated in part by this receptor as well as their previously characterized targets, the neurotransmitter transporter proteins.
Trace Amine-Associated Receptor 1 Modulates Dopaminergic Activity
TLDR
The data reveal Taar1 as regulator of dopaminergic neurotransmission as revealed by enhanced amphetamine-triggered increases in locomotor activity and augmented striatal release of dopamine compared with wild-type animals.
Altered Dopamine Release and Uptake Kinetics in Mice Lacking D2 Receptors
TLDR
Results from D2-null mutant mice support the suggestion that D2 autoreceptors and dopamine transporters interact to regulate the amplitude and timing of dopamine signals.
Modafinil Occupies Dopamine and Norepinephrine Transporters in Vivo and Modulates the Transporters and Trace Amine Activity in Vitro
TLDR
The present data provide compelling evidence that modafinil occupies the DAT and NET in living brain of rhesus monkeys and raise the possibility that modAFinil affects wakefulness by interacting with catecholamine transporters in brain.
Trace amines: Identification of a family of mammalian G protein-coupled receptors
TLDR
Using a degenerate PCR approach, 15 G protein-coupled receptors (GPCR) from human and rodent tissues are identified and it is demonstrated that two of these receptors bind and/or are activated by trace amines.
...
1
2
3
4
5
...